Atlas Trials

Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab

Clinical trial NCT01363739 · UNKNOWN

Trial details

NCT number
NCT01363739
Sponsor
Azienda Ospedaliero, Universitaria Pisana
Status
UNKNOWN
Study type
OBSERVATIONAL
Metastatic Colorectal Cancer
Start date
2009-04-01
Enrollment
265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.